Overall, these findings suggest that the SPP1-CD44 interaction plays a significant role in the upregulation of signaling among these cell types, while HLA-DRA-CD4 is crucial for downregulation, highlighting the complexity of signaling dynamics within the tumor microenvironment. The gene discussed is CD4; the disease is neoplasm.